These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23956256)

  • 1. Vancomycin dosing in children: what is the question?
    Cole TS; Riordan A
    Arch Dis Child; 2013 Dec; 98(12):994-7. PubMed ID: 23956256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin serum concentrations in pediatric oncologic/hematologic intensive care patients.
    Silva DC; Seixas GT; Araujo OR; Arduini RG; Carlesse FA; Petrilli AS
    Braz J Infect Dis; 2012; 16(4):361-5. PubMed ID: 22846125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AUC versus peak-trough dosing of vancomycin: applying new pharmacokinetic paradigms to an old drug.
    Brown DL; Lalla CD; Masselink AJ
    Ther Drug Monit; 2013 Aug; 35(4):443-9. PubMed ID: 23851909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.
    Frymoyer A; Guglielmo BJ; Hersh AL
    Pediatr Infect Dis J; 2013 Oct; 32(10):1077-9. PubMed ID: 23652479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balancing vancomycin efficacy and nephrotoxicity: should we be aiming for trough or AUC/MIC?
    Patel K; Crumby AS; Maples HD
    Paediatr Drugs; 2015 Apr; 17(2):97-103. PubMed ID: 25644329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin dosing and target attainment in children.
    Hwang D; Chiu NC; Chang L; Peng CC; Huang DT; Huang FY; Chi H
    J Microbiol Immunol Infect; 2017 Aug; 50(4):494-499. PubMed ID: 26462708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
    Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
    Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
    Eiland LS; English TM; Eiland EH
    Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relationship Between Vancomycin Trough Concentrations and AUC/MIC Ratios in Pediatric Patients: A Qualitative Systematic Review.
    Tkachuk S; Collins K; Ensom MHH
    Paediatr Drugs; 2018 Apr; 20(2):153-164. PubMed ID: 29344778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients.
    Ploessl C; White C; Manasco K
    Pediatr Infect Dis J; 2015 Oct; 34(10):e244-7. PubMed ID: 26121203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovative approaches to optimizing the delivery of vancomycin in individual patients.
    Pai MP; Neely M; Rodvold KA; Lodise TP
    Adv Drug Deliv Rev; 2014 Nov; 77():50-7. PubMed ID: 24910345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a protocol for administration of vancomycin by continuous infusion: pharmacokinetic, pharmacodynamic and toxicological aspects.
    Ampe E; Delaere B; Hecq JD; Tulkens PM; Glupczynski Y
    Int J Antimicrob Agents; 2013 May; 41(5):439-46. PubMed ID: 23523733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin dosing in children and young adults: back to the drawing board.
    Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
    Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin pharmacokinetic-pharmacodynamic parameters to optimize dosage administration in critically ill children.
    Giachetto GA; Telechea HM; Speranza N; Oyarzun M; Nanni L; Menchaca A
    Pediatr Crit Care Med; 2011 Nov; 12(6):e250-4. PubMed ID: 21057350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Vancomycin AUC/MIC and Trough Concentration With Early Clinical Response in Enterococcus or Coagulase-Negative Staphylococcus Infection: A Prospective Study.
    Pitayakittiwong C; Sermsappasuk P; Meesing A; Jaisue S
    J Clin Pharmacol; 2024 Aug; 64(8):1006-1014. PubMed ID: 38639115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin: a 50-something-year-old antibiotic we still don't understand.
    Schilling A; Neuner E; Rehm SJ
    Cleve Clin J Med; 2011 Jul; 78(7):465-71. PubMed ID: 21724929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study.
    Li J; Udy AA; Kirkpatrick CM; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2012 Jan; 39(1):69-72. PubMed ID: 22024354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved vancomycin dosing in children using area under the curve exposure.
    Le J; Bradley JS; Murray W; Romanowski GL; Tran TT; Nguyen N; Cho S; Natale S; Bui I; Tran TM; Capparelli EV
    Pediatr Infect Dis J; 2013 Apr; 32(4):e155-63. PubMed ID: 23340565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing the Clinical Use of Vancomycin.
    Álvarez R; López Cortés LE; Molina J; Cisneros JM; Pachón J
    Antimicrob Agents Chemother; 2016 May; 60(5):2601-9. PubMed ID: 26856841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.